Read More Pharma Industry News GSK reshapes ViiV Healthcare ownership as Shionogi replaces Pfizer with $2.1bn investment Pfizer exits ViiV Healthcare as Shionogi boosts its stake to 21.7%. Find out how GSK is reshaping HIV strategy with a streamlined ownership structure. byVenkateshJanuary 26, 2026